Sukhvinder Johal

Statistics

Publications

Citations

246

H-Index

Active since

1994

Affiliations

PAREXEL International (United Kingdom)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Sukhvinder Johal is an author at PAREXEL International (United Kingdom) specializing in cost-effectiveness analysis, pharmacy, and cost-effectiveness.

Publications per year

1994–2019

Publications

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

Caitlin Smare, Khalid Lakhdari, Justin Doan et al. · PharmacoEconomics · 2019 · 58 citations · Full text

Pharmacy, Biostatistics, Oncology +17

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany

Maureen Watt, Charles McCrea, Sukhvinder Johal et al. · Infection · 2016 · 45 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States

Charles McCrea, Sukhvinder Johal, Shuo Yang et al. · Experimental Hematology and Oncology · 2018 · 24 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Mifamurtide for High-Grade, Resectable, Nonmetastatic Osteosarcoma Following Surgical Resection: A Cost-Effectiveness Analysis

Sukhvinder Johal, Stephen Ralston · Value in Health · 2013 · 23 citations · Full text

Medicine, Oncology, Surgery +11

Mydriasert pupillary dilation for cataract surgery: an economic and clinical study

Ameet Shah, Sukhvinder Johal, Nicholas Lee · BMC Ophthalmology · 2015 · 16 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

1–5 of 11